High-performance liquid chromatographic assay for the quantitation of irbesartan (SR 47436/BMS-186295) in human plasma and urine
- 1 November 1997
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 702 (1-2) , 149-155
- https://doi.org/10.1016/s0378-4347(97)00387-3
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Hemodynamic and Biochemical Effects of the AT 1 Receptor Antagonist Irbesartan in HypertensionHypertension, 1995
- Angiotensin II Receptor Blockade: An Innovative Approach to Cardiovascular PharmacotherapyThe Journal of Clinical Pharmacology, 1993
- Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure.Circulation, 1993
- Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studiesEuropean Journal of Drug Metabolism and Pharmacokinetics, 1991
- PharmacokineticsPublished by Taylor & Francis ,1982
- The application of statistical moment theory to the evaluation ofin vivo dissolution time and absorption timeJournal of Pharmacokinetics and Biopharmaceutics, 1980
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977